| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $156.3M | +59.5% |
| Cost of Revenue | $3.1M | -70.6% |
| R&D Expense | $234.6M | +25.6% |
| SG&A Expense | $78.7M | -2.8% |
| Operating Income | -$159.5M | +11.1% |
| Income Tax | $0 | — |
| Net Income | -$257.4M | -11.6% |
| EPS (Basic) | -$0.69 | +11.5% |
| EPS (Diluted) | -$0.69 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $76.1M | -57.4% |
| Short-term Investments | $14.7M | +0.0% |
| Accounts Receivable | $25.8M | +842.6% |
| Current Assets | $112.4M | -47.3% |
| Total Assets | $313.9M | -24.1% |
| Current Liabilities | $255.9M | +35.4% |
| Long-term Debt | $12.8M | +1.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$224.2M | -27.8% |
| Capital Expenditures | $10.0M | -81.2% |
| Investing Cash Flow | $3.4M | +110.1% |
| Financing Cash Flow | $119.9M | +25.1% |
| Free Cash Flow | -$234.2M | -2.5% |
| +11.5% |
| Stockholders' Equity |
| -$160.3M |
| -161.6% |